Join a Clinical Trial
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.
Clinical Trial Details
Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors
Complete Title: A Multicenter Phase 1, Open-Label Study of SQ3370 in Patients with Advanced Solid Tumors
Trial Phase: I/II
Investigator: Michael Wagner, MD
The purpose of this study is to evaluate the safety, tolerability, and preliminary activity of SQ3370 in patients with advanced solid tumors.
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Contact Us
If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.
Adult
I/II
Michael Wagner, MD
RG1122026
NCT04106492
A Multicenter Phase 1, Open-Label Study of SQ3370 in Patients with Advanced Solid Tumors